CHCT,HROW Stock Price and Quote

Peers: XRN UHT HR NHP DHC DOC MPT AHR VTR LTC

| Held by: VNQ KBWY VTI IWM SDIV VXF IWN SCHH VTWO SCHA

Index	RUT
Market Cap	369.63M
Enterprise Value	931.47M
Income	17.93M
Sales	124.78M
Book/sh	14.46
Cash/sh	0.09
Dividend Est.	1.62 (12.56%)
Dividend TTM	1.76 (13.67%)
Dividend Ex-Date	Aug 19, 2026
Dividend Gr. 3/5Y	2.40% 2.26%
Payout	2435.40%
Employees	35
IPO	May 21, 2015

P/E	19.40
Forward P/E	26.33
PEG	0.27
P/S	2.96
P/B	0.89
P/C	138.44
P/FCF	9.54
EV/EBITDA	11.48
EV/Sales	7.46
Quick Ratio	2.24
Current Ratio	2.24
Debt/Eq	1.36
LT Debt/Eq	1.36
Option/Short	Yes / Yes

EPS (ttm)	0.66
EPS next Y	0.49
EPS next Q	0.09
EPS this Y	350.00%
EPS next Y	36.11%
EPS next 5Y	98.95%
EPS past 3/5Y	-54.31% -37.30%
Sales past 3/5Y	7.46% 9.87%
EPS Y/Y TTM	271.76%
Sales Y/Y TTM	5.66%
EPS Q/Q	111.75%
Sales Q/Q	7.35%
Earnings	Nov 03 AMC
EPS/Sales Surpr.	-45.45% -2.51%

Insider Own	6.60%
Insider Trans	0.96%
Inst Own	82.80%
Inst Trans	8.89%
ROA	1.82%
ROE	4.21%
ROIC	1.83%
Gross Margin	46.07%
Oper. Margin	30.50%
Profit Margin	14.37%
SMA20	-3.81%
SMA50	-9.03%
SMA200	-21.67%
Trades

Shs Outstand	28.66M
Shs Float	26.76M
Short Float	2.92%
Short Ratio	2.12
Short Interest	0.78M
52W High	19.17 -32.69%
52W Low	12.58 2.54%
Volatility	2.46% 2.30%
ATR (14)	0.33
RSI (14)	35.96
Beta	0.63
Rel Volume	0.00
Avg Volume	368.67K
Volume	0

Perf Week	0.94%
Perf Month	-10.48%
Perf Quarter	-32.18%
Perf Half Y	-25.78%
Perf YTD	-21.44%
Perf Year	-11.58%
Perf 3Y	-53.41%
Perf 5Y	-72.96%
Perf 10Y	-45.01%
Recom	1.80
Target Price	16.60
Prev Close	12.90
Price	12.90
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-17-26	Initiated	Huntington	Outperform	$20
Sep-16-24	Upgrade	Evercore ISI	Underperform → In-line	$21 → $18
May-01-24	Downgrade	Piper Sandler	Overweight → Neutral	$36 → $26
Nov-02-23	Downgrade	Evercore ISI	Outperform → In-line	$36 → $32
Sep-22-23	Downgrade	Robert W. Baird	Outperform → Neutral	$43 → $33
Jan-13-23	Upgrade	Janney	Neutral → Buy	$44
Nov-25-20	Upgrade	Evercore ISI	In-line → Outperform
Nov-05-20	Reiterated	B. Riley Securities	Neutral	$47 → $49
Sep-30-20	Resumed	Robert W. Baird	Outperform	$51
Sep-09-20	Initiated	Colliers Securities	Buy	$52
Jun-08-20	Downgrade	Evercore ISI	Outperform → In-line	$43
May-07-20	Downgrade	B. Riley FBR	Buy → Neutral	$40
Mar-30-20	Upgrade	DA Davidson	Neutral → Buy	$55 → $40
Mar-20-20	Upgrade	B. Riley FBR	Neutral → Buy	$47 → $40
Nov-18-19	Upgrade	Sandler O'Neill	Hold → Buy
Jul-10-19	Downgrade	Janney	Buy → Neutral
Apr-23-19	Initiated	Berenberg	Buy	$41
Apr-10-19	Initiated	Robert W. Baird	Outperform
Apr-05-19	Downgrade	Sandler O'Neill	Buy → Hold
Mar-28-19	Initiated	DA Davidson	Neutral

Show Previous Ratings

Oct-26-26 07:21PM	Community Healthcare Trust Faces First Proof Test Of Its Post-Dividend-Cut Turnaround Plan (Earnings Whispers)
Oct-14-26 06:27PM	Community Healthcare Trust Announces Third Quarter Earnings Release Date And Conference Call (PR Newswire)
Aug-05-26 05:07PM	Community Healthcare Trust Inc (CHCT) (Q2 2026) Earnings Call Highlights: Strategic Dividend ... (GuruFocus.com) -13.10%
Aug-04-26 04:38PM	Community Healthcare Trust: Q2 Earnings Snapshot (Associated Press)
04:15PM	Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026 (PR Newswire)
05:30PM	Loading…
Jul-17-26 05:30PM	Community Healthcare Trust Announces Second Quarter Earnings Release Date And Conference Call (PR Newswire)
Jun-24-26 04:45PM	Community Healthcare Trust Releases 2025 Corporate Sustainability Report (PR Newswire)
May-05-26 04:55PM	Community Healthcare Trust: Q1 Earnings Snapshot (Associated Press)
04:15PM	Community Healthcare Trust Announces Results for the Three Months Ended March 31, 2026 (PR Newswire)
Apr-30-26 06:38PM	Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend (PR Newswire)
Apr-13-26 05:30PM	Community Healthcare Trust Announces First Quarter Earnings Release Date And Conference Call (PR Newswire)
Feb-23-26 09:40AM	Should Value Investors Buy Apple Hospitality REIT (APLE) Stock? (Zacks)
Feb-18-26 04:05PM	Community Healthcare Trust Inc (CHCT) Q4 2025 Earnings Call Highlights: Revenue Growth and ... (GuruFocus.com)
11:55AM	Community Healthcare Trust Q4 Earnings Call Highlights (MarketBeat)
Feb-17-26 06:30PM	Here's What Key Metrics Tell Us About Community Healthcare Trust (CHCT) Q4 Earnings (Zacks)
05:45PM	Loading…
05:45PM	Community Healthcare Trust (CHCT) Lags Q4 FFO and Revenue Estimates (Zacks)
04:54PM	Community Healthcare Trust: Q4 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended December 31, 2025 (PR Newswire)
Feb-12-26 06:02PM	Community Healthcare Trust Incorporated Announces Increased Fourth Quarter Dividend (PR Newswire)
Feb-11-26 10:45AM	Truist Raises Community Healthcare Trust (CHCT) Target to $20 in 2026 REIT Outlook (Insider Monkey)
09:21AM	Implied Volatility Surging for Community Healthcare Trust Stock Options (Zacks)
Feb-02-26 05:35PM	Healthpeak (DOC) Beats Q4 FFO and Revenue Estimates (Zacks)
Jan-27-26 06:55PM	Boston Properties (BXP) Q4 FFO and Revenues Lag Estimates (Zacks)
Jan-21-26 09:35AM	Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call (PR Newswire)
Jan-19-26 09:27AM	3 Things Investors Need to Know About Invesco KBW Premium Yield Equity REIT ETF in 2026 (Motley Fool)
Dec-03-25 05:27PM	Community Healthcare Trust Announces the Closing of Recent Capital Recycling Real Estate Transactions (PR Newswire)
Nov-06-25 08:01AM	If You Invested $10K In Community Healthcare Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
Oct-30-25 03:51PM	Community Healthcare Trust Inc (CHCT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Oct-28-25 06:30PM	Compared to Estimates, Community Healthcare Trust (CHCT) Q3 Earnings: A Look at Key Metrics (Zacks)
05:45PM	Community Healthcare Trust (CHCT) Beats Q3 FFO and Revenue Estimates (Zacks)
04:45PM	Loading…
04:45PM	Community Healthcare Trust: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2025 (PR Newswire)
09:57AM	What To Expect From Community Healthcare Trust Inc (CHCT) Q3 2025 Earnings (GuruFocus.com)
Oct-27-25 09:41AM	Community Healthcare Trust Inc (CHCT) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-23-25 06:05PM	Community Healthcare Trust Incorporated Announces Increased Third Quarter Dividend (PR Newswire)
Oct-03-25 04:30PM	Community Healthcare Trust Announces Third Quarter Earnings Release Date And Conference Call (PR Newswire)
09:50AM	Is the Options Market Predicting a Spike in CHCT Stock? (Zacks)
Jul-31-25 03:24AM	Community Healthcare Trust Inc (CHCT) Q2 2025 Earnings Call Highlights: Strategic Acquisitions ... (GuruFocus.com)
Jul-29-25 06:30PM	Community Healthcare Trust (CHCT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:40PM	Community Healthcare Trust (CHCT) Lags Q2 FFO and Revenue Estimates (Zacks)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2025 (PR Newswire)
09:57AM	Community Healthcare Trust Inc (CHCT) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-28-25 09:36AM	Community Healthcare Trust Inc (CHCT) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-24-25 04:30PM	Community Healthcare Trust Incorporated Announces Increased Second Quarter Dividend (PR Newswire)
Jul-01-25 05:40PM	Community Healthcare Trust Announces Second Quarter Earnings Release Date And Conference Call (PR Newswire)
Jun-11-25 06:09PM	Community Healthcare Trust Releases 2024 Corporate Sustainability Report (PR Newswire)
Jun-04-25 10:31AM	Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks (Zacks)
May-06-25 04:30PM	Community Healthcare Trust Incorporated Announces Key Leadership Change (PR Newswire)
07:21AM	Community Healthcare Trust Incorporated (CHCT): A Top Dividend Challenger in 2025 (Insider Monkey)
May-03-25 09:54AM	Community Healthcare Trust: Evaluating Upside Potential For A Strategic Buyer (Seeking Alpha)
01:26AM	Dividend Champion, Contender, And Challenger Highlights: Week Of May 4 (Seeking Alpha)
May-01-25 03:14AM	Community Healthcare Trust Inc (CHCT) Q1 2025 Earnings Call Highlights: Steady Growth Amid ... (GuruFocus.com)
Apr-30-25 01:56PM	Community Healthcare Trust Incorporated (CHCT) Q1 2025 Earnings Call Transcript (Seeking Alpha) +5.04%
Apr-29-25 07:00PM	Community Healthcare Trust (CHCT) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Community Healthcare Trust (CHCT) Surpasses Q1 FFO and Revenue Estimates (Zacks)
04:43PM	Community Healthcare Trust: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended March 31, 2025 (PR Newswire)
Apr-24-25 05:44PM	Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend (PR Newswire)
Apr-11-25 10:01PM	How Much Would It Take To Earn $100 A Month From Community Healthcare Stock (Benzinga)
Apr-10-25 10:27AM	First Industrial Realty Trust (FR) Moves 7.6% Higher: Will This Strength Last? (Zacks) -7.19%
Apr-07-25 07:30AM	Mousetraps: 9 High-Yield REITS With Potentially Unsafe Dividends (Seeking Alpha)
Apr-02-25 06:00PM	Community Healthcare Trust Announces First Quarter Earnings Release Date And Conference Call (PR Newswire)
Feb-20-25 02:09AM	Community Healthcare Trust Inc (CHCT) Q4 2024 Earnings Call Highlights: Navigating Challenges ... (GuruFocus.com)
12:33AM	Q4 2024 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 04:54AM	Community Healthcare Trust Inc (CHCT) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) -6.31%
Feb-18-25 06:30PM	Community Healthcare Trust (CHCT) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:50PM	Community Healthcare Trust (CHCT) Q4 FFO Top Estimates (Zacks)
05:00PM	Community Healthcare Trust: Q4 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended December 31, 2024 (PR Newswire)
02:50AM	Earnings To Watch: Community Healthcare Trust Inc (CHCT) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 05:42PM	Community Healthcare Trust Incorporated Announces Increased Fourth Quarter Dividend (PR Newswire)
Jan-16-25 05:15PM	Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call (PR Newswire)
Dec-18-24 09:40AM	Should Value Investors Buy Community Healthcare Trust (CHCT) Stock? (Zacks)
Dec-13-24 08:30PM	KBW Announces Index Rebalancing for Fourth-Quarter 2024 (GlobeNewswire)
Dec-02-24 02:21PM	Are Investors Undervaluing Community Healthcare Trust (CHCT) Right Now? (Zacks)
Nov-15-24 09:40AM	Is Community Healthcare Trust (CHCT) Stock Undervalued Right Now? (Zacks)
Oct-31-24 04:08AM	Q3 2024 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
04:06AM	3 Scary High-Yield Dividend Stocks That Income Investors Should Avoid Right Now (Motley Fool)
03:13AM	Community Healthcare Trust Inc (CHCT) Q3 2024 Earnings Call Highlights: Revenue Growth and ... (GuruFocus.com)
Oct-29-24 06:30PM	Community Healthcare Trust (CHCT) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +6.70%
05:45PM	Community Healthcare Trust (CHCT) Surpasses Q3 FFO and Revenue Estimates (Zacks)
04:43PM	Community Healthcare Trust: Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2024 (PR Newswire)
09:15AM	Community Healthcare Trust Inc (CHCT) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
09:00AM	Long-Term Rewards: 3 REITs That Just Increased Dividends and Extended Their Streaks (ADC, GTY, CHCT) (Benzinga)
Oct-28-24 09:07AM	Community Healthcare Trust Inc (CHCT) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-24-24 06:00PM	Community Healthcare Trust Incorporated Announces Increased Third Quarter Dividend (PR Newswire) +5.13%
Oct-20-24 02:39PM	Community Healthcare Trust Incorporated (CHCT): Among the Worst Performing REITs in 2024 (Insider Monkey)
Oct-17-24 03:08PM	State Street Corp's Strategic Reduction in Community Healthcare Trust Inc Holdings (GuruFocus.com)
Oct-16-24 04:30PM	Community Healthcare Trust Incorporated Announces Upsizing and Maturity Extension of $400 Million Senior Unsecured Line of Credit (PR Newswire)
Oct-09-24 03:34PM	Community Healthcare Trust Inc (CHCT) Q2 2024 Earnings Call Highlights: Navigating Revenue ... (GuruFocus.com)
05:29AM	Got $5,000? Supercharge Your Passive Income With These 5 Ultra-High-Yield, High-Risk Dividend Stocks. (Motley Fool)
Oct-04-24 06:15AM	Is This 10%-Yielding Dividend Stock's Magnificent Growth Streak About to Come to an Abrupt End? (Motley Fool)
Oct-01-24 06:19PM	Community Healthcare Trust Announces Third Quarter Earnings Release Date And Conference Call (PR Newswire)
Sep-11-24 01:17PM	Director Van Horn R. Lawrence Acquires 10,000 Shares of Community Healthcare Trust Inc (CHCT) (GuruFocus.com)
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Aug-06-24 11:30PM	Insider Buying: CEO David Dupuy Acquires Shares of Community Healthcare Trust Inc (GuruFocus.com)
Aug-05-24 03:00PM	5 REITs Get Downgrades This Week (Benzinga)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dupuy David H.	CEO and President	Aug 14 '26	Buy	15.13	10,000	151,300	557,262	Aug 17 04:15 PM
Hensley Robert Z	Director	Aug 11 '26	Buy	15.21	8,000	121,680	103,702	Aug 12 04:15 PM
Cotman Cathrine	Director	Nov 04 '25	Buy	14.66	4,000	58,640	37,635	Nov 05 04:15 PM

Community Healthcare Trust, Inc. is a healthcare real estate company, which engages in acquiring real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. The company was founded by Timothy G. Wallace, William Page Barnes, Leigh Ann Stach, Ron Hart, Bill Davis, Stephen M. Harrison, Mike Willman, and Jim Short on March 28, 2014 and is headquartered in Franklin, TN.

CEOMr. David H. Dupuy

Executive VPMr. William G. Monroe IV

Executive VP & Chief Accounting OfficerMs. Leigh Ann Stach

Senior Vice President of Asset ManagementMr. Mark E. Kearns

VP & ControllerGary Moothart

Peers: BLCO ANIP TARS OCUL ALC OCS EYPT OTLK ALDX KPRX

| Held by: VTI IWM VXF IWO DFAS XPH FESM VTWO SCHA IHE

Index	RUT
Market Cap	1.09B
Enterprise Value	1.31B
Income	-37.23M
Sales	275.59M
Book/sh	0.41
Cash/sh	2.24
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	373
IPO	Apr 24, 2007

P/E	-
Forward P/E	13.37
PEG	-
P/S	3.97
P/B	71.89
P/C	13.03
P/FCF	217.68
EV/EBITDA	48.58
EV/Sales	4.75
Quick Ratio	2.08
Current Ratio	2.24
Debt/Eq	19.79
LT Debt/Eq	19.72
Option/Short	Yes / Yes

EPS (ttm)	-1.00
EPS next Y	2.18
EPS next Q	0.19
EPS this Y	47.62%
EPS next Y	3072.74%
EPS next 5Y	-
EPS past 3/5Y	35.17% -1.53%
Sales past 3/5Y	45.39% 40.99%
EPS Y/Y TTM	-244.96%
Sales Y/Y TTM	21.05%
EPS Q/Q	-459.56%
Sales Q/Q	10.85%
Earnings	Nov 09 AMC
EPS/Sales Surpr.	-157.27% 0.44%

Insider Own	15.18%
Insider Trans	0.07%
Inst Own	57.56%
Inst Trans	3.21%
ROA	-9.77%
ROE	-114.80%
ROIC	-11.82%
Gross Margin	73.28%
Oper. Margin	2.07%
Profit Margin	-13.51%
SMA20	0.07%
SMA50	-13.18%
SMA200	-24.53%
Trades

Shs Outstand	37.48M
Shs Float	31.80M
Short Float	23.51%
Short Ratio	13.13
Short Interest	7.47M
52W High	54.85 -46.86%
52W Low	26.96 8.12%
Volatility	4.02% 4.72%
ATR (14)	1.44
RSI (14)	41.83
Beta	0.16
Rel Volume	0.15
Avg Volume	569.21K
Volume	4,188

Perf Week	3.85%
Perf Month	-7.75%
Perf Quarter	-24.64%
Perf Half Y	-27.99%
Perf YTD	-40.51%
Perf Year	-23.77%
Perf 3Y	112.62%
Perf 5Y	205.24%
Perf 10Y	971.69%
Recom	1.00
Target Price	65.00
Prev Close	28.95
Price	29.15
Change %	0.69%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Initiated	Leerink Partners	Outperform	$45
Jul-11-25	Initiated	Cantor Fitzgerald	Overweight	$76
Jun-12-25	Initiated	BTIG Research	Buy	$62
Jun-10-25	Initiated	William Blair	Outperform
Feb-06-25	Initiated	H.C. Wainwright	Buy	$57
Dec-04-24	Reiterated	B. Riley Securities	Buy	$73 → $69
Apr-11-24	Initiated	Craig Hallum	Buy	$24
Sep-08-22	Resumed	B. Riley Securities	Buy	$17
Oct-14-21	Resumed	B. Riley Securities	Buy	$16
Sep-24-21	Initiated	Aegis Capital	Buy	$15
Jul-02-21	Initiated	Ladenburg Thalmann	Buy	$14.25

Show Previous Ratings

Oct-26-26 07:00AM	Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026 (GlobeNewswire)
Oct-05-26 07:00AM	Harrow Closes Acquisition of TYRVAYA (GlobeNewswire)
Sep-30-26 07:00AM	Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO (GlobeNewswire)
Sep-01-26 07:00AM	Harrow to Participate in Three Investor Conferences in September (GlobeNewswire)
Aug-20-26 07:00AM	Harrow Announces IHEEZO Data in Patient-Reported Discomfort Following Intravitreal Injections (GlobeNewswire)
03:01PM	Loading…
Aug-11-26 03:01PM	Harrow Inc (HROW) (Q2 2026) Earnings Call Highlights: Record Demand and Strategic Expansion ... (GuruFocus.com)
Aug-10-26 05:50PM	Harrow: Q2 Earnings Snapshot (Associated Press)
04:05PM	Harrow Announces Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-06-26 07:00AM	Harrow Acquires Global Rights to TYRVAYA, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease (GlobeNewswire)
Jul-27-26 07:00AM	Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026 (GlobeNewswire)
Jul-20-26 08:00AM	Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ / AMELIVU), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026 (GlobeNewswire)
07:00AM	Harrow Highlights Growing Clinical Evidence Supporting IHEEZO and BYOOVIZ at ASRS 2026 Annual Meeting (GlobeNewswire)
Jul-01-26 07:00AM	Samsung Bioepis Relaunches BYOOVIZ (ranibizumab-nuna) in the United States in Partnership with Harrow (Business Wire)
07:00AM	Harrow Announces Commercial Launch of BYOOVIZ in the United States (GlobeNewswire)
Jun-10-26 07:00AM	Harrow Re-Launches VERKAZIA (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare (GlobeNewswire) +7.29%
07:00AM	Loading…
May-27-26 07:00AM	Harrow to Present at William Blair's 46th Annual Growth Stock Conference (GlobeNewswire)
May-12-26 03:01PM	Harrow Inc (HROW) Q1 2026 Earnings Call Highlights: Strong Product Demand Amid Revenue Challenges (GuruFocus.com) -23.69%
May-11-26 04:37PM	Harrow: Q1 Earnings Snapshot (Associated Press)
04:05PM	Harrow Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-27-26 07:00AM	Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 (GlobeNewswire)
Apr-16-26 07:00AM	Harrow Announces the Issuance of J-Code for IOPIDINE 1% (GlobeNewswire)
Apr-14-26 10:30AM	LogiCare3PL Selected as Distribution Partner by Harrow (PR Newswire)
Mar-24-26 04:57PM	Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 (GlobeNewswire)
08:15AM	Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth (GlobeNewswire)
Mar-18-26 07:00AM	Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting (GlobeNewswire)
Mar-09-26 09:03PM	Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions (GuruFocus.com)
Mar-04-26 07:00AM	Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference (GlobeNewswire)
Mar-03-26 04:14PM	Why Harrow, An IBD 50 Stock Up 32% Since January, Just Crashed (Investor's Business Daily) -27.96%
11:18AM	Harrow Q4 Earnings Call Highlights (MarketBeat)
08:11AM	Why Is Eye-Disease-Focused Harrow Stock Falling Today? (Benzinga)
07:00AM	Loading…
07:00AM	Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication (GlobeNewswire)
Mar-02-26 06:00PM	Harrow (HROW) Misses Q4 Earnings Estimates (Zacks)
05:08PM	Harrow: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance (GlobeNewswire)
Feb-28-26 09:32AM	Harrow, Inc. (HROW): A Bull Case Theory (Insider Monkey)
Feb-27-26 12:58PM	These Growth Stocks Form Classic Cup Bases. Here's Where To Buy. (Investor's Business Daily)
Feb-26-26 05:35AM	TheStreet Pro: Four Stocks that Will Win Despite Irrational Panic over AI (TipRanks)
Feb-24-26 10:00AM	Esperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy? (Zacks)
08:00AM	Analysts Boost Profit Forecasts On Two Names. One Is A Data Center Play. (Investor's Business Daily)
Feb-23-26 02:20PM	Why IBD Stock Of The Day Harrow Has Its Sights On A Breakout (Investor's Business Daily)
10:00AM	Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-18-26 07:00AM	Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 (GlobeNewswire)
Feb-17-26 06:01PM	Private Capital's Strategic Moves: ECN Capital Corp Exit Impacts Portfolio by -3.57% (GuruFocus.com) +5.98%
07:00AM	Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack Kits (GlobeNewswire)
Feb-04-26 01:07PM	Eye Care Stock Sees New Path After Guidance (Investor's Business Daily)
Feb-03-26 06:28AM	Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? (Zacks) +5.10%
Feb-02-26 07:00AM	Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270-$280 Million, Marking Another Year of Strong Growth (GlobeNewswire) +9.67%
Jan-15-26 01:00PM	Harrow, Inc. (HROW): A Bull Case Theory (Insider Monkey)
08:55AM	Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength (Zacks)
Dec-09-25 12:56PM	Eye Drops Maker Sets Up After Strategic Buy; Sales Outlook Strong (Investor's Business Daily)
Nov-24-25 07:00AM	Harrow to Present at Two Investor Conferences in December (GlobeNewswire)
Nov-18-25 07:00AM	Harrow Announces Closing of Acquisition of Melt Pharmaceuticals (GlobeNewswire)
Nov-14-25 05:03PM	Private Capital's Strategic Moves: Spotlight on Matthews International Corp (GuruFocus.com) +7.65%
Nov-11-25 02:01PM	Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans (GuruFocus.com) +13.47%
Nov-10-25 04:31PM	Harrow: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Harrow Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-27-25 07:00AM	Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 (GlobeNewswire)
Oct-08-25 11:23AM	Harrow, Inc. (HROW): A Bull Case Theory (Insider Monkey) -5.14%
Oct-06-25 07:00AM	ImprimisRx Announces Leadership Changes (GlobeNewswire) -7.20%
Sep-26-25 08:57AM	Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever? (Benzinga)
07:00AM	Harrow to Acquire Melt Pharmaceuticals (GlobeNewswire)
Sep-25-25 04:05PM	Harrow Launches Harrow Access for All (HAFA) (GlobeNewswire)
Sep-15-25 07:00AM	Harrow Announces Agenda and Speakers for Investor & Analyst Day (GlobeNewswire) +8.63%
Sep-08-25 05:57PM	Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 (GlobeNewswire) +7.52%
08:00AM	Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030 (GlobeNewswire)
Sep-02-25 04:07AM	Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea (Insider Monkey)
Aug-26-25 04:15AM	Harrow, Inc. (HROW): A Bull Case Theory (Insider Monkey)
Aug-15-25 12:20PM	Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock (Zacks)
10:00AM	Best Momentum Stock to Buy for August 15th (Zacks)
09:55AM	Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet (Zacks)
Aug-14-25 02:36PM	Harrow Stock Eyes Relative Strength Rating Upgrade (Investor's Business Daily) +9.62%
Aug-11-25 05:55PM	Harrow: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Harrow Announces Second-Quarter 2025 Financial Results (GlobeNewswire)
09:23AM	Harrow Inc (HROW) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-08-25 09:22AM	Harrow Inc (HROW) Q2 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Aug-06-25 07:00AM	Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference (GlobeNewswire)
Aug-04-25 10:00AM	Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks) +7.01%
Jul-29-25 07:00AM	Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 (GlobeNewswire)
Jul-21-25 03:34PM	Harrow, Inc. (HROW): A Bull Case Theory (Insider Monkey)
Jul-17-25 07:00AM	Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States (Business Wire)
07:00AM	Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States (Business Wire)
Jul-14-25 10:01AM	Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar? (Zacks)
Jul-12-25 09:40AM	CoreWeave initiated, Texas Instruments upgraded: Wall Streets top analyst calls (TipRanks)
Jul-11-25 09:38AM	CoreWeave initiated, Texas Instruments upgraded: Wall Street's top analyst calls (The Fly) +11.35%
Jul-06-25 04:15AM	William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating (Insider Monkey)
Jul-02-25 09:00AM	Are Options Traders Betting on a Big Move in Harrow Stock? (Zacks)
Jun-18-25 07:00AM	Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications (Business Wire)
Jun-09-25 07:00AM	Harrow Acquires U.S. Commercial Rights to BYQLOVI (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals (Business Wire)
May-14-25 10:07AM	Jim Cramer on Harrow, Inc. (HROW) - "Eye Care's a Good Biz - If It Makes Money, Don't Walk Away Pre-Breakout" (Insider Monkey)
07:00AM	Harrow to Present at Two Investor Conferences in May (Business Wire)
May-10-25 03:03AM	Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
May-08-25 05:10PM	Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Harrow Announces First-Quarter 2025 Financial Results (Business Wire)
09:32AM	Harrow Inc (HROW) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-07-25 10:28AM	What To Expect From Harrow Inc (HROW) Q1 2025 Earnings (GuruFocus.com)
May-05-25 07:00AM	Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 (Business Wire)
Apr-30-25 07:35AM	United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-29-25 07:35AM	What Recession? I'm Swimming In Dividends (Seeking Alpha)
Apr-24-25 10:00AM	NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension) (PR Newswire) +5.20%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AMIR SHOJAEI	CHIEF SCIENTIFIC OFFICER	Aug 14 '26	Proposed Sale	40.00	11,250	450,000		Aug 21 06:32 PM
Shojaei Amir	CHIEF SCIENTIFIC OFFICER	Aug 14 '26	Option Exercise	35.96	11,250	404,550	11,250	Aug 17 05:47 PM
Shojaei Amir	CHIEF SCIENTIFIC OFFICER	Aug 14 '26	Sale	40.00	11,250	450,000	0	Aug 17 05:47 PM
Graves Adrienne L	Director	May 18 '26	Buy	31.07	1,000	31,070	1,000	May 19 07:00 AM
SILVERNAIL LAUREN P	Director	May 18 '26	Buy	31.00	1,000	31,000	1,000	May 19 07:00 AM
BAUM MARK L	CHIEF EXECUTIVE OFFICER	May 14 '26	Buy	30.20	10,000	302,000	2,996,130	May 15 07:01 AM
BOLL ANDREW R.	PRESIDENT AND CFO	May 14 '26	Buy	29.90	3,500	104,650	814,679	May 15 07:00 AM
Opaleye Management Inc.	10% Owner	Mar 04 '26	Sale	39.67	138,263	5,485,184	59,428	Mar 05 04:05 PM
Opaleye Management Inc.	10% Owner	Mar 03 '26	Sale	39.15	60,309	2,361,242	63,691	Mar 05 04:05 PM
Opaleye Management Inc.	10% Owner	Feb 27 '26	Sale	54.18	5,000	270,900	65,000	Mar 03 04:05 PM
Opaleye Management Inc.	10% Owner	Jan 06 '26	Sale	53.35	20,000	1,066,914	70,000	Jan 08 04:05 PM
BOLL ANDREW R.	PRESIDENT AND CFO	Dec 12 '25	Option Exercise	3.95	60,000	237,000	837,844	Dec 16 08:50 PM
BAUM MARK L	CHIEF EXECUTIVE OFFICER	Dec 12 '25	Option Exercise	3.95	180,000	711,000	3,066,124	Dec 16 08:48 PM

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company's FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company's ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

CEOMr. Mark L. Baum J.D.

C.M.A.Mr. Andrew R. Boll C.F.A.

Pharm.D.Dr. Amir W. Shojaei Ph.D.

President & CEO of Harrow's ImprimisRx DivisionMr. Francis W. Mullery

Vice President of Investor Relations & CommunicationsMr. Michael D. Biega

CHCT

Community Healthcare Trust Inc

HROW

Harrow Inc

Upgrade your Finviz experience